Limited effectiveness of patent blue dye in addition to isotope scanning for identification of sentinel lymph nodes: Cross-sectional real-life study in 1024 breast cancer patients.
Fiche publication
Date publication
septembre 2016
Journal
International journal of surgery (London, England)
Auteurs
Membres identifiés du Cancéropôle Est :
Pr HARLE Alexandre, Pr MARCHAL Frédéric, Pr MERLIN Jean-Louis, Pr OLIVIER Pierre, Dr LEUFFLEN Léa
Tous les auteurs :
Rauch P, Merlin JL, Leufflen L, Salleron J, Harlé A, Olivier P, Marchal F
Lien Pubmed
Résumé
Although morbidity is reduced when sentinel lymph node (SLN) biopsy is performed with dual isotopic and blue dye identification, the effectiveness of adding blue dye to radioisotope remains debated because side effects including anaphylactic reactions.
Mots clés
Adult, Aged, Axilla, Breast Neoplasms, diagnostic imaging, Coloring Agents, Cross-Sectional Studies, Female, Humans, Lymphatic Metastasis, Lymphoscintigraphy, Mastectomy, Middle Aged, Radioisotopes, Radiopharmaceuticals, Retrospective Studies, Sentinel Lymph Node, diagnostic imaging, Sentinel Lymph Node Biopsy, methods
Référence
Int J Surg. 2016 Sep;33 Pt A:177-81